Saudi Grocer Bindawood Offers Investors Chance to Cancel Bids After Loan Disclosure
(Bloomberg) -- Saudi Arabia's BinDawood Holding Co. is giving institutional investors the chance to amend or cancel their IPO bids after disclosing 284 million riyals ($76 million) in loans to related parties.
Institutional investors will have until Oct. 5 to make changes, BinDawood said in an update to the intial public offering prospectus released Thursday. Under the original timeline, the institutional offering period closed on Sept. 22 and the final allotment should have taken place on Oct. 1. A planned offering to retail investors will now take place from Oct. 8 to Oct. 12.
BinDawood said it lent the money to Amwaj Real Estate Co. and AQimma Hotels Co. between July and September. The loans have since been repaid. Board members Abdulrazzag Dawood BinDawood, Abdulkhaliq Dawood BinDawood, and Khalid Dawood BinDawood have indirect ownership in the two companies.
It remains unclear how the revelations will impact investor appetite for the share sale, which aims to raise about $600 million and was already more than 50 times oversubscribed when the IPO process was put on hold last week, people familiar with the matter told Bloomberg last week.
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
